Anemia in COPD: Should it be taken into consideration?;La anemia en la EPOC. ¿Debemos pensar en ello?

Archivos de Bronconeumologia

Volumn 43, Issue 7, 2007, Pages 392-398

  Carroz, Karina Portillo ^a  

^a HOSPITAL DOS DE MAIG   (Spain)

Author keywords

Anemia; COPD; Erythrocytosis

Indexed keywords

ANDROGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANEMIA; CANCER; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DYSPNEA; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HEALTH; HEART FAILURE; HEMATOPOIESIS; HUMAN; INFLAMMATION; LUNG FIBROSIS; MORTALITY; MUSCLE DISEASE; NONHUMAN; OSTEOPOROSIS; OXYGEN THERAPY; PATHOPHYSIOLOGY; PROGNOSIS; QUALITY OF LIFE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESPIRATORY TRACT DISEASE; REVIEW; SURVIVAL; WEIGHT REDUCTION;

EID: 34548418068     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S1579-2129(07)60091-3     Document Type: Review

References (37)

1. Braunwald E. Hipoxia, policitemia y cianosis. En: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editores. Harrison. Principios de medicina interna. Madrid: McGraw-Hill Interamericana; 1998. p. 235-9.
2. Hillman R. Anemia. En: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editores. Harrison. Principios de medicina interna. Madrid: McGraw-Hill Interamericana; 1998. p. 379-84.
3. World Health Organization. Nutritional anemia: report of a WHO Scientific Group. Geneva: World Health Organization; 1968. Tech Rep Ser. 1968;405:5-37.
4. Pavlisa G, Vrbanic V, Kusec V, Jaksic B. Erythropoietin response after correction of severe hypoxaemia due to acute respiratory failure in chronic obstructive pulmonary disease patients. Clin Sci. 2004;106:43-51.
5. Hillman R. Anemia ferropénica y otras anemias hipoproliferativas. En: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editores. Harrison. Principios de medicina interna. Madrid: McGraw-Hill Interamericana; 1998. p. 729-37.
6. Similowski T, Agustí A, MacNee W, Schonhofer B. The potential impact of anaemia of chronic disease in COPD. Eur Respir J. 2006;27:390-6.
7. Tassiopoulos S, Kontos A, Konstantopoulos K, Hadzistavrou C, Vaiopoulos G, Aessopos A, et al. Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease. Respir Med. 2001;95: 471-5.
8. John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD. Anemia and inflammation in COPD. Chest. 2005;127:825-9.
9. Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:367-70.
10. Wouters E. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:26-33.
11. Hurst JR, Perera WR, Wilkinson TM, Donaldson GC, Wedzicha JA. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173:71-8.
12. Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax. 2006;61:23-8.
13. Sin DD, Man SF. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax. 2006;61:1-3.
14. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011-23.
15. Tsantes AE, Papadhimitriou SI, Tassiopoulos ST, Bonovas S, Paterakis G, Meletis I, et al. Red cell macrocytosis in hypoxemic patients with chronic obstructive pulmonary disease. Respir Med. 2004;98:1117-23.
16. García-Pachón E, Padilla-Navas I. Red cell macrocytosis in COPD patients without respiratory insufficiency: a brief report. Respir Med. 2007;101:349-52.
17. Andreas S, Anker SD, Scanlon PD, Somers VK. Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest. 2005;128:3618-25.
18. Vlahakos DV, Marathias KP, Agroyannis B, Madias NE. Post-transplant erythrocytosis. Kidney Int. 2003;63:1187-94.
19. Vlahakos D, Kosmas E, Dimopoulou I, Ikonomou E, Jullien G, Vassilakos P, et al. Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease. Am J Med. 1999;106:158-64.
20. Pham I, Andrivet P, Sediame S, Defouilloy C, Moutereau S, et al. Increased erythropoietin synthesis in patients with COLD or left heart failure is related to alterations in renal haemodynamics. Eur J Clin Invest. 2001;31:103-9.
21. Tsantes AE, Tassiopoulos ST, Papadhimitriou SI, Bonovas S, Poulakis N, Vlachou A, et al. Theophylline treatment may adversely affect the anoxia-induced erythropoietic response without suppressing erythropoietin production. Eur J Clin Pharmacol. 2003;59:379-83.
22. Casaburi R, Bhasin S, Cosentino L, Porszasz J, Somfay A, Lewis MI, et al. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:870-8.
23. Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, Ble A, et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med. 2006;166:1380-8.
24. Silverberg DS, Wexler D, Blum M, Schwartz D, Wollman Y, Iaina A. The cardio-renal anaemia syndrome: does it exist? Nephrol Dial Transplant. 2003;18 Suppl 8:7.
25. Lupón J, Urrutia A, González B, Herreros J, Altimir S, Coll R, et al. Significado pronóstico de los valores de hemoglobina en pacientes con insuficiencia cardíaca. Rev Esp Cardiol. 2005;58:48-53.
26. Horwich T, Fonarow G, Hamilton M, MacLellan W, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002;39: 1780-6.
27. John M, Lange A, Hoernig S, Witt C, Anker SD. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol. 2006;111:365-70.
28. Tsantes A, Bonovas S, Tassiopoulos S, Filioussi K, Vlachou A, Meletis J, et al. A comparative study of the role of erythropoietin in the pathogenesis of deficient erythropoiesis in idiopathic pulmonary fibrosis as opposed to chronic obstructive pulmonary disease. Med Sci Monit. 2005;11:CR177-81.
29. O'Connor TM, McGrath DS, Short C, O'Donnell MJ, Sheehy M, Bredin CP. Subclinical anaemia of chronic disease in adult patients with cystic fibrosis. J Cyst Fibros. 2002;1:31-4.
30. Gutiérrez V, Olivera M, Girón R, Rodríguez- Salvanés F, Caballero P. Fibrosis quística en adultos: acuerdos inter e intraobservador para las escalas de puntuación de Brasfield y Chrispin-Norman en la radiografía de tórax y relación con datos clínicos y espirométricos. Arch Bronconeumol. 2005;41:553-9.
31. Cantón R, Cobos N, De Gracia J, Baquero F, Honorato J, Gartner S, et al (en representación del Grupo Español de Consenso del Tratamiento Antimicrobiano en el Paciente con Fibrosis Quística). Tratamiento antimicrobiano frente a la colonización pulmonar por Pseudomonas aeruginosa en el paciente con fibrosis quística. Arch Bronconeumol. 2005;41:1-25.
32. Schonhofer B, Wenzel M, Geibel M, Kohler D. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med. 1998;26:1824-8.
33. Schonhofer B, Bohrer H, Kohler D. Importance of blood transfusion in anemic patients with COPD and unsuccessful weaning from respirator. Med Klin. 1999;Suppl 1:108-10.
34. Celli BR, Cote CG, Marín JM, Casanova C, Montes de Oca M, Méndez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005-12.
35. Chambellan A, Chailleux E, Similowski T; ANTADIR Observatory Group. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest. 2005;128: 1201-8.
36. Martínez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, et al; NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med. 2006;173:1326-34.
37. Celli B. Predicting mortality in chronic obstructive pulmonary disease: chasing the "Holy Grail". Am J Respir Crit Care Med. 2006; 173:1298-9.